Literature DB >> 6471919

Serial echocardiographic observations in patients with primary systemic amyloidosis: an introduction to the concept of early (asymptomatic) amyloid infiltration of the heart.

L Cueto-Garcia, A J Tajik, R A Kyle, W D Edwards, P R Greipp, J A Callahan, C Shub, J B Seward.   

Abstract

Echocardiography was used for the serial assessment of 27 patients with primary systemic amyloidosis. Thirteen patients had no clinical cardiac deterioration between the two echocardiographic studies (group 1), whereas in 14 patients (group 2), congestive heart failure or arrhythmias (or both) appeared or worsened during a mean observation period of 19 months. The only echocardiographic changes in group 1 were a mild increase in left ventricular mass and a mild decrease in left ventricular wall systolic thickening. Patients in group 2 had significant changes in left ventricular wall thickness (mean increase, 34%), in left ventricular mass (mean increase, 42%), in right ventricular wall thickness (mean increase, 78%), in left atrial size (mean increase, 19%), in left ventricular mass/voltage ratio (mean increase, 68%), in left ventricular radius/thickness ratio (mean decrease, 29%), and in left ventricular fractional shortening (mean decrease, 13%). Significant correlations were found in group 2 between changes in systolic and diastolic blood pressure and changes in ventricular wall thickness and mass. Changes in left ventricular systolic function did not correlate significantly with changes in other clinical, electrocardiographic, or echocardiographic measurements. In six cases (two in group 1), in which amyloid infiltration of the heart was proved by myocardial biopsy or autopsy, the only echocardiographic abnormality when the patients were asymptomatic was a moderate increase in left or right ventricular wall thickness. We found that M-mode and two-dimensional echocardiographic examinations can substantiate progressive amyloid infiltration of the heart and are useful tools for the noninvasive serial assessment of patients with primary systemic amyloidosis.

Entities:  

Mesh:

Year:  1984        PMID: 6471919     DOI: 10.1016/s0025-6196(12)62409-4

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  11 in total

Review 1.  Restrictive cardiomyopathy.

Authors:  P T Wilmshurst; D Katritsis
Journal:  Br Heart J       Date:  1990-06

2.  Advanced cardiac amyloidosis associated with normal interventricular septal thickness: an uncommon presentation of infiltrative cardiomyopathy.

Authors:  Rahul Suresh; Martha Grogan; Joseph J Maleszewski; Patricia A Pellikka; Mazen Hanna; Angela Dispenzieri; Naveen L Pereira
Journal:  J Am Soc Echocardiogr       Date:  2014-01-18       Impact factor: 5.251

3.  Is technetium-99 m-pyrophosphate scintigraphy valuable in the diagnosis of cardiac amyloidosis?

Authors:  A Hartmann; J Frenkel; R Hopf; R P Baum; G Hör; M Schneider; M Kaltenbach
Journal:  Int J Card Imaging       Date:  1990

4.  Magnetic Resonance Imaging in Cardiac Amyloidosis: Unraveling the Stealth Entity.

Authors:  Omair Shah; Naseer Choh; Tahleel Shera; Faiz Shera; Tariq Gojwari; Feroze Shaheen; Irfan Robbani
Journal:  Int J Angiol       Date:  2021-09-21

5.  Cardiac amyloidosis responding to bortezomib: case report and review of literature.

Authors:  Edriss Charaf; Said B Iskandar; Ashley Blevins; Bernard Abi-Saleh; Stephen Fahrig
Journal:  Curr Cardiol Rev       Date:  2009-08

Review 6.  Use of Noninvasive Imaging in Cardiac Amyloidosis.

Authors:  Raymundo Alain Quintana-Quezada; Syed Wamique Yusuf; Jose Banchs
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-07

Review 7.  Primary systemic amyloidosis.

Authors:  Morie A Gertz; S Vincent Rajkumar
Journal:  Curr Treat Options Oncol       Date:  2002-06

8.  Indexed left ventricular mass to QRS voltage ratio is associated with heart failure hospitalizations in patients with cardiac amyloidosis.

Authors:  Jeremy A Slivnick; Alexander L Wallner; Ajay Vallakati; Vien T Truong; Wojciech Mazur; Mohamed B Elamin; Matthew S Tong; Subha V Raman; Karolina M Zareba
Journal:  Int J Cardiovasc Imaging       Date:  2020-10-17       Impact factor: 2.357

9.  Cardiac amyloidosis diagnosed by endomyocardial biopsy.

Authors:  M A Kim; C H Kim; B H Oh; Y B Park; Y S Choi; J D Seo; Y W Lee
Journal:  Korean J Intern Med       Date:  1988-07       Impact factor: 2.884

10.  Incidence, diagnosis and prognosis of cardiac amyloidosis.

Authors:  Min-Ho Lee; Seung-Pyo Lee; Yong-Jin Kim; Dae-Won Sohn
Journal:  Korean Circ J       Date:  2013-11-30       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.